blog

TSO and MS: Phase 1 Clincal Trial Complete

The Phase 1 clinical trial of TSO for treatment of Multiple Sclerosis, conducted by Dr.Fleming at the University of Wisconsin School of Medicine and Public Health, is now complete. No adverse effects in the 5 patients, and a reduction of MRI-measured brain leasions in all 5. The abstract

continue reading >>

Article on TSO and my son in The Scientist

The story of my son and our experience with TSO is chronicled in an article in the February, 2001 issue of The Scientist. The author provides a lot of background information on the Hygiene Hypothesis and the work of Doctors Weinstock, Elliott and Summers on Crohn’s Disease and Ulcerative

continue reading >>

Textbook chapter on my experience with TSO

I have authored a chapter describing my experience with TSO in Textbook of Autism Spectrum Disorders, published by APPI.  The chapter is titled “An Experimental Treatment for Autism“‘. (Note: I received no compensation for this, nor do I receive any compensation from sales of the textbook)

continue reading >>

Scientists uncover a mechanism of action in helminth therapy

IL-22 CD4 T Cells are involved in therapeutic T. trichuria infection in Ulcerative Colitis. Sci Transl Med 2010: Dec 1;2(60):60ra88

continue reading >>

OCD Immune link

OCD behavior in mice has been linked to the Hoxb8 gene. Hoxb8 is found in microglia, immune cells that guard against pathogens. This study was reported in Science Now. A podcast interview with the Nobel Laureate that did the study plus a link to the actual published article appear in the

continue reading >>